SEC Tracker
Get the app

Gossamer Bio GOSS

Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Gossamer Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
  2. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  3. Standard Biotools LAB public float $291M, Jun 30, 2025
  4. Aquestive Therapeutics AQST public float $292M, Jun 30, 2025
  5. Heron Therapeutics HRTX public float $235M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.